What is the clinical evidence from this study?

Study design: Review. Population: Obesity. Intervention: Thermogenic adipose tissue targeted therapies.

What does this research mean for the field?

Translating thermogenic adipose tissue into a viable clinical therapy requires moving beyond [18F]FDG imaging to a multimodal framework that accounts for human heterogeneity and UCP1-independent pathways. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To review the obstacles in translating brown and beige adipose tissue research into clinical therapeutics and propose a framework accounting for human tissue heterogeneity.

September 8, 2026Nutrition & MetabolismOpen Access

Targeting thermogenic adipose tissue for obesity requires multimodal assessments that account for human tissue heterogeneity.

View Full Paper

Ask AI

Bookmark

Why the study?

Translating thermogenic adipose tissue breakthroughs into practical obesity treatments has been hindered by reliance on imaging surrogates rather than direct thermogenic measurement, and poor translation of rodent findings to complex human fat depots.

Design

Review

Key result

Thermogenic adipose tissue is a promising therapeutic target for obesity, but successful clinical translation requires multimodal functional assessments and strategies that account for human tissue heterogeneity.

Authors

CXChunli Xia LYLihui Yan WGWenqing Guan

Discussion

Member takes

Overview

Cautions against premature clinical targeting of thermogenic adipose tissue in obesity; leaves open optimal multimodal assessment strategies for human heterogeneity.

Key Points

To review the obstacles in translating brown and beige adipose tissue research into clinical therapeutics and propose a framework accounting for human tissue heterogeneity.
Narrative review synthesizing mechanistic rodent studies and recent atlas-scale human adipose depot data.
Evaluation of clinical imaging surrogates, specifically 18F-fluorodeoxyglucose positron emission tomography, alongside alternate thermogenic assessment modalities.
Translational failure stems from over-reliance on glucose uptake imaging surrogates and rodent models that fail to capture human depot patchiness and microenvironmental variation.
A multimodal assessment framework is introduced to separate adipose tissue presence, acute recruitment, and true functional thermogenic output.
Emerging therapeutic approaches require targeting uncoupling protein 1-independent energy pathways, mitochondrial quality control, and inter-organ crosstalk rather than classical thermogenesis alone.

PICO

Population

Obesity

Intervention / Comparator

Thermogenic adipose tissue targeted therapies

This review emphasizes the need for multimodal functional assessments and consideration of human tissue heterogeneity to successfully translate thermogenic adipose tissue targets into clinical obesity therapies.

Limitations

Translational challenges from rodents to humans
Reliance on imaging surrogates like [18F]FDG-PET/CT rather than direct thermogenic output
Significant heterogeneity in human thermogenic adipose tissue
Safety and tolerability concerns with systemic adrenergic stimulation

Cite This Study

Xia et al. (2026) conducted a review in Obesity. Thermogenic adipose tissue targeted therapies was evaluated. Thermogenic adipose tissue is a promising therapeutic target for obesity, but successful clinical translation requires multimodal functional assessments and strategies that account for human tissue heterogeneity.

synapsesocial.com/papers/6a9fd79b58e84d0ff5b4666e https://doi.org/10.1186/s12986-026-01208-y

View Full Paper

Ask AI

Bookmark

September 8, 2026Nutrition & MetabolismOpen Access

Targeting thermogenic adipose tissue for obesity requires multimodal assessments that account for human tissue heterogeneity.

View Full Paper

Ask AI

Bookmark

Why the study?

Design

Review

Key result

Authors

CXChunli Xia LYLihui Yan WGWenqing Guan

Discussion

Member takes

Overview

Cautions against premature clinical targeting of thermogenic adipose tissue in obesity; leaves open optimal multimodal assessment strategies for human heterogeneity.

Key Points

To review the obstacles in translating brown and beige adipose tissue research into clinical therapeutics and propose a framework accounting for human tissue heterogeneity.
Narrative review synthesizing mechanistic rodent studies and recent atlas-scale human adipose depot data.
Evaluation of clinical imaging surrogates, specifically 18F-fluorodeoxyglucose positron emission tomography, alongside alternate thermogenic assessment modalities.
Translational failure stems from over-reliance on glucose uptake imaging surrogates and rodent models that fail to capture human depot patchiness and microenvironmental variation.
A multimodal assessment framework is introduced to separate adipose tissue presence, acute recruitment, and true functional thermogenic output.
Emerging therapeutic approaches require targeting uncoupling protein 1-independent energy pathways, mitochondrial quality control, and inter-organ crosstalk rather than classical thermogenesis alone.

PICO

Population

Obesity

Intervention / Comparator

Thermogenic adipose tissue targeted therapies

Limitations

Translational challenges from rodents to humans
Reliance on imaging surrogates like [18F]FDG-PET/CT rather than direct thermogenic output
Significant heterogeneity in human thermogenic adipose tissue
Safety and tolerability concerns with systemic adrenergic stimulation

Cite This Study

synapsesocial.com/papers/6a9fd79b58e84d0ff5b4666e https://doi.org/10.1186/s12986-026-01208-y

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark